Roche
ROG.SW
#36
Rank
NZ$556.03 B
Marketcap
NZ$693.09
Share price
2.12%
Change (1 day)
43.32%
Change (1 year)

EPS for Roche (ROG.SW)

EPS in 2023: NZ$29.59

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$29.59. In 2023 the company made an earnings per share (EPS) of NZ$29.59 an increase over its 2022 EPS that were of NZ$29.03.

EPS history for Roche from 1998 to 2023

Annual EPS

Year EPS Change
2023NZ$29.591.95%
2022NZ$29.03-6.29%
2021NZ$30.97-5.53%
2020NZ$32.7916.56%
2019NZ$28.1330.3%
2018NZ$21.5920.22%
2017NZ$17.96-5.81%
2016NZ$19.064.62%
2015NZ$18.22-5.13%
2014NZ$19.21-25.05%
2013NZ$25.6321.73%
2012NZ$21.053.82%
2011NZ$20.288.16%
2010NZ$18.7523.72%
2009NZ$15.15-12.31%
2008NZ$17.28-0.34%
2007NZ$17.3432.13%
2006NZ$13.1242.56%
2005NZ$9.20-22.7%
2004NZ$11.91132.85%
2003NZ$5.11-149.34%
2002NZ-$10.36-209.09%
2001NZ$9.50-57.25%
2000NZ$22.2254.06%
1999NZ$14.4231.24%
1998NZ$10.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.04-39.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.12-55.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.97-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.40-78.36%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
NZ$12.72-57.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
NZ$6.21-79.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Abbott Laboratories
ABT
NZ$13.92-52.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$22.51-23.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$9.62-67.48%๐Ÿ‡บ๐Ÿ‡ธ USA